Life Science Business Value of Blockchain Case Use

Blockchain Real World Deployment Taking Bad Actors and Counterfeit Drugs off the Market

Authors

  • Daniel Laverick, Head of SAP and IT Solutions, Zuellig Pharma 

DOI:

https://doi.org/10.30953/bhty.v5.203

Keywords:

COVID-19 vaccine distribution, vaccine value chain, cold chain infrastructure, traceability of vaccines, issue identification, tracking serialized products , serialization coding standards, counterfeit Covid-19 vaccines, traceability of pharma supply chain, authenticity of drugs, eZTracker , blockchain in healthcare

Abstract

How is blockchain technology empowering patients to verify provenance and quality of COVID-19 vaccines and other lifesaving drugs through Asia's first blockchain solution for supply chain connectivity and traceability for pharmaceuticals and vaccines?

With two million products on the blockchain network, this ground breaking scalable initiative controls "pack" vs "batch." Authorities are now seizing counterfeits and consumers are benefitting by verifying their drug(s) are effective and can be trusted as safe and efficacious.

Why use blockchain and what are the vaccine management issues along the pharma supply chain?

Downloads

Download data is not yet available.

Downloads

Published

2022-07-01

How to Cite

Laverick, Head of SAP and IT Solutions, Zuellig Pharma , D. (2022). Life Science Business Value of Blockchain Case Use: Blockchain Real World Deployment Taking Bad Actors and Counterfeit Drugs off the Market. Blockchain in Healthcare Today, 5(S2). https://doi.org/10.30953/bhty.v5.203

Issue

Volume 5, 2022 - ConV2X Symposium Multimedia Special Issue

Section

Conference Presentations

License

Copyright (c) 2022 Daniel Laverick, Head of SAP and IT Solutions, Zuellig Pharma 

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors retain copyright of their work, with first publication rights granted to Blockchain in Healthcare Today (BHTY). Read the full Copyright Statement.